Aspirin plus medium intensity Coumadin versus aspirin alone in the prevention of reocclusion after successful thrombolysis for suspected acute myocardial infarction: Results of the APRICOT-2 trial

Brouwer, MA; van den Bergh, PJPC; Vromans, RPJW; Aengevaeren, WRM; Veen, G; Luijten, HE; Hertzberger, DP; van Boven, AJ; Uijen, GJH; Verheugt, FWA

Aspirin plus medium intensity Coumadin versus aspirin alone in the prevention of reocclusion after successful thrombolysis for suspected acute myocardial infarction: Results of the APRICOT-2 trial

Author:

Brouwer, MA

van den Bergh, PJPC ; Vromans, RPJW ; Aengevaeren, WRM ; Veen, G ; Luijten, HE ; Hertzberger, DP ; van Boven, AJ ; Uijen, GJH ; Verheugt, FWA

Keywords:

Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, 1102 Cardiorespiratory Medicine and Haematology, 1117 Public Health and Health Services, Cardiovascular System & Hematology, 3201 Cardiovascular medicine and haematology

Aspirin plus medium intensity Coumadin versus aspirin alone in the prevention of reocclusion after successful thrombolysis for suspected acute myocardial infarction: Results of the APRICOT-2 trial

Author:

Keywords:

About us

Our services

Our solutions